Page 3 - Jonathanc Fox News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathanc fox. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathanc Fox Today - Breaking & Trending Today

Edgewise Therapeutics (NASDAQ:EWTX) Sets New 12-Month High at $13.11

Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) hit a new 52-week high during trading on Friday . The stock traded as high as $13.11 and last traded at $13.08, with a volume of 3033292 shares traded. The stock had previously closed at $9.69. Wall Street Analyst Weigh In Separately, Wedbush lowered their […] ....

Jonathanc Fox , Alanj Russell , Edgewise Therapeutics Inc , Tower Research Capital , Edgewise Therapeutics Company Profile , Schonfeld Strategic Advisors , Securities Exchange Commission , Principal Financial Group Inc , Royal Bank , Group Plc , Edgewise Therapeutics , Get Free Report , Director Jonathan , Exchange Commission , General Group Plc , Research Capital , Financial Group , Edgewise Therapeutics Daily , Nasdaq Ewtx ,

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Up to $10.05

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Up to $10.05
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Alanj Russell , Jonathanc Fox , Geode Capital Management , Blackrock Inc , Goldman Sachs Group Inc , Securities Exchange Commission , Edgewise Therapeutics Company Profile , Edgewise Therapeutics Inc , Vanguard Group Inc , Edgewise Therapeutics , Get Free Report , Director Jonathan , Exchange Commission , Sachs Group , Capital Management , Edgewise Therapeutics Daily ,

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Short Interest Update

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 8,500,000 shares, a growth of 20.9% from the November 30th total of 7,030,000 shares. Currently, 23.7% of the company’s shares are short sold. Based on an […] ....

Johnr Moore , Jonathanc Fox , Blackrock Inc , Vanguard Group Inc , Metlife Investment Management , Edgewise Therapeutics Inc , Jpmorgan Chase Co , Edgewise Therapeutics , Get Free Report , Director Jonathan , General Counsel John , Life Investment Management , Vanguard Group , Edgewise Therapeutics Daily , Nasdaq Ewtx ,